Perspective on Roseroot (Rhodiola rosea) Studies

Abstract

Rhodiola rosea (roseroot) extract is a commercially successful product, primarily used to reduce the effect of fatigue on physical and mental performance. In this perspective we present our investigation of the most recent studies performed on human subjects. With a focus on the statistical methods we found considerable shortcomings in all but one of the studies that claim significant improvement from roseroot extract. Overall, the study designs have not been well explained. Experimental results have been confused and appear to be in some cases incorrect. Some of the conclusions are based on selected results and contradicting data have not been adequately taken into account. We point to other studies of higher quality performed on roseroot, several that found no significant effect and one that did. We conclude that the currently available evidence for the claimed effects is insufficient and that the effect of Rhodiola rosea is in need of further investigation before therapeutic claims can be made.

Key words

Rhodiola rosea - Crassulaceae - adaptogen - statistics

References

• 1 Spasov A A, Wikman G, Mandrikov V B, Mironova I A, Neumoin V V. A double-blind, placebo-controlled pilot study of the stimulating and adaptogenic effect of Rhodiola rosea SHR‐5 extract on the fatigue of students caused by stress during an examination period with a repeated low-dose regimen.  Phytomedicine. 2000;  7 85-89
• 2 Spasov A A, Mandrikov V B, Mironova I A. Effect of Rhodaxon preparation on the psychophysiological and physical adaptations of students to learning load.  Eksp Klin Pharmacol. 2000;  63 76-78
• 3 Darbinyan V, Kteyan A, Panossian A, Gabriellian E, Wikman G, Wagner H. Rhodiola rosea in stress induced fatigue – a double blind cross-over study of a standardized extract SHR‐5 with repeated low-dose regimen on the mental performance of healthy physicians during night duty.  Phytomedicine. 2000;  7 365-371
• 4 Darbinyan V, Aslanyan G, Amroyan E, Gabrielyan E, Malmström C, Panossian A. Clinical trial of Rhodiola rosea L. extract SHR‐5 in the treatment of mild to moderate depression.  Nord J Psychiatry. 2007;  61 343-348
• 5 Walsh T. Placebo response in studies of major depression: variable, substantial, and growing.  JAMA. 2002;  287 1840-1847
• 6 Shevtsov V A, Zholus B I, Shervarly V I, Vol'skij V B, Korovin Y P, Khristich M P, Roslyakova N A, Wikman G. A randomized trial of two different doses of a SHR‐5 Rhodiola rosea extract versus placebo and control of capacity for mental work.  Phytomedicine. 2003;  10 95-105
• 7 Fintelmann V, Gruenwald J. Efficacy and tolerability of Rhodiola rosea extract in adults with physical and cognitive deficiencies.  Adv Ther. 2007;  24 929-939
• 8 Bystritsky A, Kerwin L, Feusner J D. A pilot study of Rhodiola rosea (Rhodax®) for generalized anxiety disorder (GAD).  J Altern Complement Med. 2008;  14 175-180
• 9 Olsson M G, von Schéele B, Panossian A G. A randomized, double-blind, placebo-controlled, parallel-group study of the standardised extract SHR‐5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue.  Planta Med. 2009;  75 105-112
• 10 DeBock K, Eijnde B O, Ramaekers M, Hespel P. Acute Rhodiola rosea intake can improve endurance exercise performance.  Int J Sport Nutr Exerc Metab. 2004;  14 298-307
• 11 Walker T B, Altobelli S A, Caprihan A, Robergs R A. Failure of Rhodiola rosea to alter skeletal muscle phosphate kinetics in trained men.  Metabolism. 2007;  56 1111-1117
• 12 Colson S N, Wyatt F B, Johnston D L, Autrey L D, Fitzgerald Y L, Earnest C P. Cordyceps sinensis- and Rhodiola rosea-based supplementation in male cyclist and its effect on muscle tissue oxygen saturation.  J Strength Res. 2005;  19 358-363
• 13 Earnest C P, Morss G M, Wyatt F, Jordan A N, Colson S, Church T S, Fitzgerald Y, Autery L, Jurca R, Lucia A. Effects of a commercial herbal-based formula on exercise performance in cyclists.  Med Sci Sports Exerc. 2004;  36 504-509
• 14 Walker T B, Robergs R A. Does Rhodiola rosea possess ergogenic properties?.  Int J Sport Nutr Exerc Metab. 2006;  16 305-315
• 15 Roland P D, Amundstuen L. Roseroot, statements and documentation.  Tidsskr Nor Lægeforen. 2007;  127 882-883